Tirzepatide, a recently approved medication, is generating excitement as a possible treatment for individuals living with diabetes type 2 . Unlike existing diabetes medications , it operates through a innovative mechanism, activating both glucagon-like peptide-1 and the GIP hormone receptors. Clinical trials have illustrated that tirzepatide can su